Christian Spirig

454 total citations
7 papers, 42 citations indexed

About

Christian Spirig is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Christian Spirig has authored 7 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Christian Spirig's work include Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Christian Spirig is often cited by papers focused on Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Christian Spirig collaborates with scholars based in Switzerland, Chile and Italy. Christian Spirig's co-authors include Thomas Ruhstaller, Aurelius Omlin, Giannicola DʼAddario, Jens Huober, Roger von Moos, Markus Ackermann, Müller Hk, Khalil Zaman, Daniel Rauch and Sun Young Rha and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Medical Case Reports.

In The Last Decade

Christian Spirig

6 papers receiving 40 citations

Peers

Christian Spirig

ONCOL

EPIDE

BIOMA

DERMA

MB

Riley Ennis United States

Jasmine Tran United States

Kate Turner Australia

Robert Rogers United States

Bertrand Bachollet France

Jessica M. Donigan United States

Kimberly B. Sprenger United States

Shoba A. Navai United States

Dolcie Paxton United Kingdom

Maly Fenelus United States

Riley Ennis United States

Christian Spirig

14 ×0.8

ONCOL

4 ×0.3

EPIDE

9 ×0.8

BIOMA

0 ×0.0

DERMA

12 ×1.7

MB

Citations per year, relative to Christian Spirig Christian Spirig (= 1×) peers Riley Ennis

Countries citing papers authored by Christian Spirig

Since Specialization

Citations

This map shows the geographic impact of Christian Spirig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Spirig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Spirig more than expected).

Fields of papers citing papers by Christian Spirig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Spirig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Spirig. The network helps show where Christian Spirig may publish in the future.

Co-authorship network of co-authors of Christian Spirig

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Spirig. A scholar is included among the top collaborators of Christian Spirig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Spirig. Christian Spirig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Balmelli, Cathrin, Michael Mark, Christian Spirig, et al.. (2014). Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations. memo - Magazine of European Medical Oncology. 7(3). 181–186.

2.

Mazières, Julien, Gérard Zalcman, Lucio Crinò, et al.. (2014). Efficacy of crizotinib in ROS1-rearranged lung cancer: The European experience.. Journal of Clinical Oncology. 32(15_suppl). 11035–11035. 3 indexed citations

3.

Rochlitz, Christoph, Thomas Ruhstaller, Christian Spirig, et al.. (2010). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Annals of Oncology. 22(1). 80–85. 21 indexed citations

4.

Spirig, Christian, et al.. (2009). Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report. Journal of Medical Case Reports. 3(1). 93–93. 11 indexed citations

5.

Rochlitz, Christoph, Christian Spirig, Thomas Ruhstaller, et al.. (2009). Bevacizumab and pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer: A multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK). Journal of Clinical Oncology. 27(15_suppl). 1030–1030. 2 indexed citations

6.

Spirig, Christian, et al.. (1989). [Serologic and virologic studies of selected cattle with antibodies to bovine herpesviruses].. PubMed. 131(4). 195–204. 2 indexed citations

7.

Spirig, Christian, et al.. (1987). [Dried whole blood on filter discs for the detection of IBR/IPV antibodies in ELISA].. PubMed. 129(10). 529–35. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact